Siran M. Koroukian, PhD

Articles by Siran M. Koroukian, PhD

Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage

ByGalen Shearn-Nance, BS,Rishi R. Sachdev, BS,Long Vu, MS,Weichuan Dong, PhD,Alberto J. Montero, MD, MBA,Siran M. Koroukian, PhD,Johnie Rose, MD, PhD

April 4th 2025

This study examined postdiagnosis breast cancer treatment outcomes for Medicare Advantage vs fee-for-service (FFS) Medicare in Ohio and found no significant differences overall but disparities for Black patients with FFS Medicare.

Comparison of Cesarean Section Rates in Fee-for-Service Versus Managed Care Patients in the Ohio Medicaid Population, 1992-1997

BySiran M. Koroukian, PhD,Donna Bush, MSW,Alfred A. Rimm, PhD

February 1st 2001

Siran M. Koroukian, PhD

Articles by Siran M. Koroukian, PhD

Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage

Comparison of Cesarean Section Rates in Fee-for-Service Versus Managed Care Patients in the Ohio Medicaid Population, 1992-1997

Latest Updated Articles

Trending on AJMC

Prior Cancer History Predicts Second Cancers in Polycythemia Vera, Essential Thrombocythemia

Medicaid MFN Pricing Could Save $8.6 Billion

Active US Drug Shortages Rise for Third Straight Quarter

CRC Treatment Delays Linked to Higher Metastasis Risk, Supporting Pathway-Specific Benchmarks

Access Barriers, Not Science, Slow Retina Care: Paul Hahn, MD